🇺🇸 FDA
Pipeline program

Escitalopram (Oral antidepressant)

2025-109

Unknown small_molecule active

Quick answer

Escitalopram (Oral antidepressant) for Depression - Major Depressive Disorder is a Unknown program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Depression - Major Depressive Disorder
Phase
Unknown
Modality
small_molecule
Status
active

Clinical trials